Reproductive Health Drugs Panel Holds On To Hager For A New Term

House members critical of FDA's "not approvable" decision on OTC emergency contraception were unsuccessful in blocking the reappointment of David Hager, MD, University of Kentucky, to the agency's Reproductive Health Drugs Advisory Committee